Compound Reference

BPC-157 (Oral)

Oral form of the gastric pentadecapeptide

Healing & repairEvidence: preclinicalRUO · WADA-prohibited
Research Use Only. Not FDA-approved; sold only as a research chemical. Many performance-adjacent peptides are also WADA-prohibited for tested athletes. Educational only — not medical advice.

What it is

An oral presentation of BPC-157, leveraging its reported stability in gastric acid. See the full BPC-157 profile for mechanism and evidence.

Proposed mechanism

Same proposed mechanisms as injectable BPC-157 (angiogenesis via VEGFR2, NO modulation); oral absorption and systemic exposure in humans are not well characterized.1

State of the evidence

Regulatory & status

References

  1. BPC-157 background (literature). globalrph.com

Explore the full library & 75-compound reference →

For educational and research purposes only. This content is not medical advice. Compounds referenced are research use only and not intended to diagnose, treat, cure, or prevent any disease. Free Peptide University does not sell compounds.